MedDataX Logo

Temporomandibular Joint in Patients With Rheumatoid Arthritis

NCT ID: NCT06134726

Last Updated: 2023-11-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

142 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-15

Study Completion Date

2023-01-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the investigators study aimed to evaluate temporomandibular joint involvement in rheumatoid arthritis patients and healthy individuals 142 participants were recruited in two groups: 72 patients with Rheumatoid Arthritis (RA), and 70 healthy controls. All participants were tested for seropositivity of rheumatoid factor and anticitrullinated protein antibodies. TMD diagnosis was determined according to the standardized and validated diagnostic criteria for TMD (DC/TMD): myalgia, arthralgia, articular disc, displacement, degenerative joint disease, and headache attributed to TMD. Bruxism, a probable sleep and/or awake bruxism diagnosis was determined based on self-report and several clinical findings.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Temporomandibular Joint Disorders Rheumatoid Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RA group

seropositivity of rheumatoid factor

Intervention Type DIAGNOSTIC_TEST

All participants were tested for seropositivity of rheumatoid factor and anticitrullinated protein antibodies

Control group

seropositivity of rheumatoid factor

Intervention Type DIAGNOSTIC_TEST

All participants were tested for seropositivity of rheumatoid factor and anticitrullinated protein antibodies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

seropositivity of rheumatoid factor

All participants were tested for seropositivity of rheumatoid factor and anticitrullinated protein antibodies

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

anticitrullinated protein antibodies

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age \> 18 years old
* individuals who had a minimum of 12 natural teeth.

Exclusion Criteria

* included: trauma or surgery on the jaw
* facial nerve paralysis
* tooth implant
* scleroderma
* cerebrovascular accident
* schizophrenia
* steroid injection within the last six months.
Minimum Eligible Age

35 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Syrian Private University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Diaa Haj Ali

medical doctor Diaa Haj Ali

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Medicine, Damascus University, Syria

Damascus, , Syria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Syria

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BX63413,2021

Identifier Type: -

Identifier Source: org_study_id